Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Licensing revenue
Expenses:
Research and development	30,296
General and administrative	801,601	1,080,039
Loss from operations	(831,897)	(1,080,039)
Other income:
Interest income	18,632	4,267
Royalty and milestone rights	1,000,000
Other income, net		1,274
Net income (loss)	186,735	(1,074,498)
Dividends paid on preferred shares		(68,809)
Net income (loss) attributable to common stockholders	$ 186,735	$ (1,143,307)
Total basic income (loss) per share	$ 0.38	$ (0.03)
Total diluted income (loss) per share	$ 0.38	$ (0.03)
Basic weighted-average shares outstanding	495,092	460,790
Diluted weighted-average shares outstanding	495,092	460,790